Literature DB >> 3126519

Cholinergic mediation of the discriminative stimulus properties of clozapine.

E B Nielsen1.   

Abstract

Rats were trained to discriminate clozapine (CLZ; 5.76 mg/kg, IP t-30 min) in a two-lever operant task in which responding on the correct lever was reinforced with water under a fixed ratio 32 schedule. The ED50 of CLZ was 1.1 mg/kg. The CLZ cue was generalised to atropine (ED50 = 8.7 mg/kg), scopolamine (ED50 = 0.37 mg/kg) and fluperlapine (ED50 = 4.0 mg/kg), but not to non-cholinergic compounds, i.e. buspirone, diazepam, ketanserin, prazosin or SCH 23390. The peripherally-acting muscarinic antagonist methylscopolamine did not substitute for CLZ. Furthermore, the CLZ cue was marginally attenuated by d-amphetamine; a high dose of oxotremorine (1 mg/kg) appeared to block the CLZ cue (to 22%). However, this effect could not be evaluated statistically due to an insufficient number of animals responding. These results may indicate that the discriminative stimulus effects of CLZ primarily involve antagonism of central muscarinic acetylcholine receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3126519     DOI: 10.1007/bf00735891

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Discriminable effects of antimuscarinics: dose response and substitution test studies.

Authors:  D A Overton
Journal:  Pharmacol Biochem Behav       Date:  1977-06       Impact factor: 3.533

2.  Generalization by rats of alcohol and atropine stimulus characteristics to other drugs.

Authors:  R K Kubena; H Barry
Journal:  Psychopharmacologia       Date:  1969

3.  Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

Authors:  D A Overton
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism.

Authors:  R J Miller; C R Hiley
Journal:  Nature       Date:  1974-04-12       Impact factor: 49.962

Review 5.  Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects.

Authors:  S Snyder; D Greenberg; H I Yamamura
Journal:  Arch Gen Psychiatry       Date:  1974-07

6.  Guanine nucleotide regulation of agonist binding to muscarinic cholinergic receptors. Relation to efficacy of agonists for stimulation of phosphoinositide breakdown and Ca2+ mobilization.

Authors:  T Evans; J R Hepler; S B Masters; J H Brown; T K Harden
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

7.  Pharmacology of fluperlapine compared with clozapine.

Authors:  E Eichenberger
Journal:  Arzneimittelforschung       Date:  1984

8.  Characterization of [3H]pirenzepine binding to muscarinic cholinergic receptors solubilized from rat brain.

Authors:  G R Luthin; B B Wolfe
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

9.  Discriminative stimulus properties of arecoline: a new approach for studying central muscarinic receptors.

Authors:  L T Meltzer; J A Rosecrans
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

10.  Specific binding of 3H-SCH 23390 to dopamine D1 receptors in vivo.

Authors:  P H Andersen; F C Grønvald
Journal:  Life Sci       Date:  1986-04-21       Impact factor: 5.037

View more
  8 in total

1.  Multiple neurochemical action of clozapine: a quantitative autoradiographic study of DA2, opiate and benzodiazepine receptors in the rat brain after long-term treatment.

Authors:  L Giardino; L Calzà; P V Piazza; G Amato
Journal:  J Neural Transm Gen Sect       Date:  1991

2.  Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice.

Authors:  Scott D Philibin; Adam J Prus; Alan L Pehrson; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

3.  Further characterization of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in C57BL/6 mice: role of 5-HT(2A) serotonergic and alpha (1) adrenergic antagonism.

Authors:  Scott D Philibin; D Matthew Walentiny; Sarah A Vunck; Adam J Prus; Herbert Y Meltzer; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2008-11-07       Impact factor: 4.530

4.  Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats.

Authors:  Joseph H Porter; Adam J Prus; Robert E Vann; Stephen A Varvel
Journal:  Psychopharmacology (Berl)       Date:  2004-08-13       Impact factor: 4.530

5.  The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats.

Authors:  Adam J Prus; Alan L Pehrson; Scott D Philibin; Jesse T Wood; Sarah A Vunck; Joseph H Porter
Journal:  Psychopharmacology (Berl)       Date:  2008-08-07       Impact factor: 4.530

Review 6.  Discriminative stimulus properties of atypical and typical antipsychotic drugs: a review of preclinical studies.

Authors:  Joseph H Porter; Adam J Prus
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

7.  Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine.

Authors:  Andrew J Goudie; Judith A Smith; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2003-09-24       Impact factor: 4.530

8.  Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice.

Authors:  Morgane Thomsen; Gitta Wörtwein; Anders Fink-Jensen; David P D Woldbye; Jürgen Wess; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2007-02-20       Impact factor: 4.415

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.